PMID- 36843587 OWN - NLM STAT- MEDLINE DCOM- 20230228 LR - 20230228 IS - 1664-2392 (Print) IS - 1664-2392 (Electronic) IS - 1664-2392 (Linking) VI - 14 DP - 2023 TI - Alternative skeletal muscle index for sarcopenia diagnosis in elderly patients with type 2 diabetes mellitus: A pilot study. PG - 1083722 LID - 10.3389/fendo.2023.1083722 [doi] LID - 1083722 AB - PURPOSE: To determine an alternative skeletal muscle index (a-SMI), easy diagnosis of sarcopenia in elderly patients with type 2 diabetes mellitus (T2DM). PATIENTS AND METHODS: This cross-sectional study included 223 inpatients with T2DM (100 males, age range 60-89; 123 females, age range 60-87). Screening for grip strength and gait speed, measuring SMI by dual-energy X-ray absorptiometry (d-SMI) for sarcopenia diagnosis, according to the Asian Working Group for Sarcopenia (AWGS) 2019 consensus. The a-SMI was established by binary logistic regression analysis with positive screening population. To assess the conformance of the new diagnostic approach with the AWGS 2019. RESULTS: Sarcopenia was present in 36.3% of the study population. 59 had normal d-SMI and 81 had low d-SMI in screening patients with probable sarcopenia. In univariate analyses for all positive screening population, body mass index (BMI), 25-hydroxyvitamin D (25 - (OH) VitD), high density lipoprotein cholesterol (HDL-C), hypertension (HTN), and gender were correlates of d-SMI. Binary logistic regression analysis revealed that male (B = 2.463, 95%CI: 3.640 ~ 37.883, p = 0.000), HTN (B = 1.404, 95%CI: 1.599 ~ 10.371, p = 0.003), BMI (B = -0.344, 95%CI: 0.598 ~ 0.839, p = 0.000), 25-(OH) VitD (B = -0.058, 95%CI: 0.907 ~ 0.982, p = 0.004) were independent factors for d-SMI detection. Based on the extracted four correlates, the a-SMI was determined. The area under receiver operating characteristic (ROC) curve was 0.842, sensitivity and specificity for the new diagnostic approach were 84.0% and 84.5%. In a statistical measure of agreement between the AWGS 2019 and the new diagnostic approach, the kappa coefficient was 0.669 (p < 0.001). CONCLUSION: The a-SMI - based on gender, obesity status, 25-(OH) VitD, and HTN history - can be used in the absence of the d-SMI to supplement the algorithm for sarcopenia diagnosis in elderly patients with T2DM. CI - Copyright (c) 2023 Lu, Liu and Yin. FAU - Lu, Lanyu AU - Lu L AD - Department of Endocrinology and Metabolic Diseases, Hebei Medical University, Shijiazhuang, Hebei, China. FAU - Liu, Bowei AU - Liu B AD - Department of Endocrinology, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, China. FAU - Yin, Fuzai AU - Yin F AD - Department of Endocrinology, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230209 PL - Switzerland TA - Front Endocrinol (Lausanne) JT - Frontiers in endocrinology JID - 101555782 SB - IM MH - Female MH - Humans MH - Male MH - Aged MH - Middle Aged MH - Aged, 80 and over MH - *Sarcopenia/diagnosis/etiology/epidemiology MH - Pilot Projects MH - *Diabetes Mellitus, Type 2/complications MH - Cross-Sectional Studies MH - Muscle, Skeletal/physiology PMC - PMC9947145 OTO - NOTNLM OT - SMI OT - T2DM OT - diagnosis OT - elderly OT - sarcopenia COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/02/28 06:00 MHDA- 2023/03/03 06:00 PMCR- 2023/01/01 CRDT- 2023/02/27 03:47 PHST- 2022/10/29 00:00 [received] PHST- 2023/01/27 00:00 [accepted] PHST- 2023/02/27 03:47 [entrez] PHST- 2023/02/28 06:00 [pubmed] PHST- 2023/03/03 06:00 [medline] PHST- 2023/01/01 00:00 [pmc-release] AID - 10.3389/fendo.2023.1083722 [doi] PST - epublish SO - Front Endocrinol (Lausanne). 2023 Feb 9;14:1083722. doi: 10.3389/fendo.2023.1083722. eCollection 2023.